MPM Bioventures 2018, L.P. is 10% Owner at iTeos Therapeutics, Inc. (ITOS). They have made 6 open-market trades across 2 companies since 2021, most recently 2026-09-09.
CIK 0001729505
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AKTS | 10,260,064 | $154.6M |
| ITOS | 2,905,494 | $29.5M |
| TRDA | 3,885,115 | $17.0M |
| Total | $201.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 83% | — |
| Avg Move | +4.0% | -6.5% | — |
| Scored | 6 | 6 | 2 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRDA | SELL | 2026-09-04 | 2026-09-09 | $7.33 | $1.9M | -3.3% | -17.2% | — |
| TRDA | SELL | 2026-09-01 | 2026-09-03 | $7.14 | $617K | -2.3% | -22.4% | — |
| TRDA | SELL | 2026-08-27 | 2026-08-31 | $7.08 | $616K | -2.9% | -9.4% | — |
| TRDA | SELL | 2026-08-24 | 2026-08-26 | $7.36 | $462K | +7.3% | -12.7% | — |
| ITOS | SELL | 2021-12-03 | 2021-12-07 | $33.72 | $3.3M | +29.8% | +26.0% | +5.6% |
| ITOS | SELL · 10b5-1 | 2021-10-07 | 2021-10-12 | $27.23 | $1.4M | +1.6% | +10.3% | +55.1% |
| ITOS | SELL · 10b5-1 | 2021-10-04 | 2021-10-05 | $27.06 | $560K | +6.1% | +12.0% | +80.1% |
| ITOS | SELL | 2021-09-21 | 2021-09-23 | $27.50 | $1.9M | -4.3% | -3.1% | +65.1% |
| ITOS | SELL · 10b5-1 | 2021-09-07 | 2021-09-08 | $29.03 | $1.2M | -5.2% | -4.8% | +16.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.